Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Transplantation

The relevance of the FAVORIT blood pressure associations

Secondary analysis of the FAVORIT data in kidney transplant recipients showed that systolic blood pressure ≥140 mmHg and diastolic blood pressure <70 mmHg at trial entry were associated with increased risks of cardiovascular disease over a mean of 4 years. Whether these blood pressure values are associated with mortality is unclear.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CVD and mortality by blood pressure in a post-hoc analysis of the FAVORIT trial data.

References

  1. Carpenter, M. A. et al. BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013040435.

  2. Bostom, A. G. et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation 123, 1763–1770 (2011).

    Article  CAS  Google Scholar 

  3. Jardine, A. G. et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am. J. Transplant. 4, 988–995 (2004).

    Article  CAS  Google Scholar 

  4. Briet, M., Boutouyrie, P., Laurent, S. & London, G. M. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 82, 388–400 (2012).

    Article  Google Scholar 

  5. Bahous, S. A., Stephan, A., Blacher, J. & Safar, M. E. Aortic stiffness, living donors, and renal transplantation. Hypertension 47, 216–221 (2006).

    Article  CAS  Google Scholar 

  6. Delahousse, M. et al. Aortic stiffness of kidney transplant recipients correlates with donor age. J. Am. Soc. Nephrol. 19, 798–805 (2008).

    Article  Google Scholar 

  7. Philipp, T. et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol. Dial. Transplant. 25, 967–976 (2010).

    Article  CAS  Google Scholar 

  8. Lentine, K. L., Axelrod, D. & Abbott, K. C. Interpreting body composition in kidney transplantation: weighing candidate selection, prognostication, and interventional strategies to optimize health. Clin. J. Am. Soc. Nephrol. 6, 1238–1240 (2011).

    Article  Google Scholar 

  9. James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel C. Brennan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lentine, K., Brennan, D. The relevance of the FAVORIT blood pressure associations. Nat Rev Nephrol 10, 366–367 (2014). https://doi.org/10.1038/nrneph.2014.79

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2014.79

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing